Welzel, T. M., Hinrichsen, H., Sarrazin, C., Buggisch, P., Baumgarten, A., Christensen, S., Berg, T., Mauss, S., Teuber, G., Stein, K., Deterding, K., van Bömmel, F., Heyne, R., John, C., Zimmermann, T., Lutz, T., Schott, E., Hettinger, J., Kleine, H., König, B., Hüppe, D., & Wedemeyer, H. (2017). real‐world experience with the all‐oral, interferon‐free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepatitis C virus infection in the German Hepatitis C Registry. Journal of viral hepatitis, 24(10), 840–849. http://access.bl.uk/ark:/81055/vdc_100049405679.0x000027